Substance-Use Treatment During Probation
Court-Ordered Substance-Use Treatment During Probation
A practical guide to evaluations, levels of care, provider selection, medication for opioid use disorder, documentation, privacy, telehealth, affordability, and treatment completion during probation and other forms of community supervision.
What does “court-ordered treatment” mean?
There is no single national form of court-ordered substance-use treatment. Treatment may become part of probation, parole, pretrial supervision, specialty-court participation, federal supervised release, or another justice-system process.
A person may be required to:
- obtain a substance-use evaluation or assessment;
- participate in counseling or treatment;
- follow authorized treatment recommendations;
- attend outpatient, intensive outpatient, or residential services;
- participate in drug or alcohol testing;
- provide participation or completion documentation;
- comply with specialty-court requirements; or
- satisfy another treatment-related condition established by a legally authorized authority.
These requirements may arise from different sources, including a judge, written supervision conditions, a specialty-court program, a supervision agency implementing an existing condition, a clinical evaluation, or a provider's treatment requirements.
The roles overlap, but they are not identical
The court or another legally authorized authority establishes the legal obligation. Depending on the jurisdiction and order, a supervision officer may also have authority to approve, coordinate, or supervise aspects of participation.
Treatment providers contribute clinical assessment, treatment planning, medical care, and professional recommendations within their scope of practice.
Exactly who controls provider selection, modality, duration, intensity, reporting, or changes in treatment depends on the governing order, jurisdiction, program, and applicable law.
Federal probation provides one example
Federal courts may impose substance-use treatment as a condition of probation or supervised release. Federal probation guidance also contemplates probation officers supervising aspects of treatment participation, including provider, location, modality, duration, and intensity, within the authority established by the court and applicable policy.
State and local systems may operate differently.
The useful question is therefore not simply “Who chooses treatment?” It is:
What does the controlling order require, what authority has been assigned to supervision, and what does the clinical assessment support?
Start with the written requirement
Before selecting a treatment provider, identify exactly what the applicable court order, judgment, supervision condition, or program requirement says.
Look for language addressing:
- substance-use evaluation or assessment;
- alcohol or drug treatment;
- counseling;
- compliance with treatment recommendations;
- frequency or duration;
- drug or alcohol testing;
- approved or accepted providers;
- geographic restrictions;
- in-person or remote participation;
- documentation requirements;
- deadlines;
- responsibility for costs;
- release-of-information requirements;
- specialty-court rules;
- medication-related provisions; and
- consequences for nonparticipation.
Terms such as evaluation, assessment, education, counseling, treatment, and follow recommendations should not automatically be treated as interchangeable.
When the requirement is unclear, seek clarification from the responsible court, attorney, supervision authority, or program rather than relying on another person's case.
Evaluation and treatment are different
A substance-use evaluation or clinical assessment helps identify treatment needs and what services, if any, may be appropriate.
An assessment may consider:
- alcohol and drug-use history;
- frequency and pattern of use;
- previous treatment;
- withdrawal history;
- physical health;
- medications;
- mental-health conditions;
- current functioning;
- safety concerns;
- recovery environment;
- housing stability;
- social supports; and
- other relevant clinical or functional factors.
An evaluation does not produce the same recommendation for every person. One individual may need education or routine outpatient services. Another may need more intensive outpatient treatment, medication, residential care, withdrawal management, or coordinated treatment for substance-use and mental-health conditions.
An order to obtain an evaluation is not automatically an order to enter a particular level of treatment. What happens next depends on the controlling legal requirement, the assessment, and any authorized subsequent instructions.
Understanding treatment settings and levels of care
Substance-use treatment is delivered across different settings and levels of intensity. Clinical need, safety, accessibility, availability, insurance, and applicable supervision requirements can all affect how services are delivered.
Outpatient treatment
Outpatient treatment generally allows a person to live in the community while attending scheduled services.
- individual counseling;
- group counseling;
- medication management;
- recovery support;
- case management;
- relapse- or recurrence-prevention planning;
- family services; and
- co-occurring mental-health treatment.
Some outpatient services can be delivered remotely when legally permitted and clinically appropriate.
Intensive outpatient treatment
Intensive outpatient programs, commonly called IOPs, generally provide a more structured and frequent schedule than routine outpatient treatment while allowing participants to remain in the community.
Program schedules and services differ among providers.
Partial hospitalization
Partial hospitalization programs and similar day-treatment models generally provide a higher level of structured care than routine outpatient treatment while allowing participants to return home outside program hours.
Residential treatment
Residential treatment involves living at a treatment facility while receiving structured services.
Programs may differ in:
- clinical staffing;
- medical capability;
- treatment model;
- length of stay;
- insurance participation;
- medication policies;
- population served;
- accessibility; and
- justice-system documentation capabilities.
A residential facility should not automatically be assumed to satisfy a particular court or supervision requirement merely because it provides addiction treatment.
Withdrawal management
Some substances can produce clinically significant or potentially dangerous withdrawal. People who may be at risk should receive appropriate medical evaluation.
Withdrawal can be a medical issue. Decisions about withdrawal management should be handled by qualified healthcare professionals rather than through self-directed cessation or nonclinical supervision instructions.
Ordered, recommended, licensed, approved and accepted are different
A provider can be properly licensed without being accepted by a particular court or supervision program.
A provider can also be accepted for one type of service but not another.
When acceptance matters, confirm it before enrolling whenever reasonably possible.
What does treatment “completion” mean?
Treatment completion is not necessarily the same as reaching a date or attending a predetermined number of sessions.
Providers may consider:
- attendance;
- engagement;
- achievement of treatment objectives;
- adherence to program requirements;
- clinical progress;
- completion of assigned services;
- discharge planning; or
- transfer to another level of care.
The justice system may separately require documentation showing that a legal condition has been satisfied.
Possible documentation may include:
- verification of enrollment;
- attendance confirmation;
- evaluation documentation;
- authorized progress reports;
- discharge documentation;
- completion certificates;
- provider correspondence; or
- documentation that required recommendations were addressed.
The document needed by a court or supervision agency is not necessarily the same thing as the provider's complete clinical record.
Successful discharge, transfer and interrupted treatment
A person may leave a treatment program for many reasons, including:
- completion of treatment objectives;
- transfer to another level of care;
- provider change;
- insurance changes;
- relocation;
- repeated missed appointments;
- program-rule violations;
- provider closure;
- hospitalization;
- declining continued services; or
- the provider no longer being able to meet the person's needs.
A discharge label does not necessarily explain the entire clinical or administrative situation.
For someone under supervision, however, interruption of treatment may also affect compliance with a legal condition.
- Clarify why participation ended.
- Determine whether further treatment is recommended.
- Identify whether a different provider or level of care is needed.
- Obtain available documentation.
- Confirm what the responsible supervision authority requires next.
What happens if someone misses treatment?
A missed appointment does not produce the same consequence in every case. Reasons can include:
- illness;
- hospitalization;
- transportation failure;
- work;
- childcare;
- housing instability;
- incarceration;
- provider cancellation;
- insurance problems;
- technology failure;
- schedule misunderstanding; or
- recurrence of substance use.
Treatment providers and supervision authorities may respond differently. A provider may address the issue clinically, while a supervision agency may separately determine whether the person complied with the applicable legal condition.
Do not assume that notifying the treatment provider automatically notifies supervision—or that notifying supervision automatically notifies the treatment provider.
When possible:
- contact the provider promptly;
- follow applicable supervision reporting instructions;
- ask about rescheduling;
- document the reason;
- preserve relevant records; and
- clarify whether additional action is required.
Never falsify attendance or completion documentation.
Positive drug or alcohol tests during treatment
A positive drug or alcohol test may have both clinical and supervision-related implications.
From a treatment perspective, recurrence of substance use may result in reassessment of:
- safety;
- treatment frequency;
- the treatment plan;
- medication;
- services; or
- level of care.
The court or supervision authority may separately evaluate the test under the person's legal conditions.
Questions that may matter
- Was abstinence expressly required?
- What substance was detected?
- Was confirmatory testing required or performed?
- Could a legitimate prescription be relevant?
- Was disclosure of prescribed medication required?
- Did treatment continue?
- Was reassessment recommended?
- What do the actual supervision conditions require?
Consequences vary by jurisdiction, case, testing method, supervision condition, and program.
Medication for opioid use disorder
Medication is an evidence-based treatment option for opioid use disorder. Federal health guidance identifies buprenorphine, methadone, and naltrexone as FDA-approved medications commonly used to treat OUD.
Treatment with appropriately prescribed medication should not automatically be characterized as continuing illicit opioid use or as a failure to pursue recovery.
Medication decisions—including selection, dose, continuation, adjustment, tapering, and discontinuation—should be handled by appropriately authorized healthcare professionals.
ADA protections and opioid use disorder
Federal disability law can protect people with opioid use disorder who are in recovery and are not currently engaging in illegal drug use, including people taking legally prescribed medication for OUD.
The U.S. Department of Justice has specifically addressed discriminatory blanket policies affecting people taking medications such as methadone or buprenorphine for OUD.
ADA protection depends on the circumstances, and current illegal drug use is treated differently under the statute.
Courts, agencies, programs, and providers should evaluate applicable disability requirements rather than assuming that prescribed medication for opioid use disorder automatically makes someone noncompliant or ineligible.
Methadone and opioid treatment programs
Methadone used to treat opioid use disorder operates under a specialized federal regulatory framework.
Federally certified opioid treatment programs (OTPs) play a central role in providing methadone for OUD and may also provide other medications and treatment services.
Federal OTP regulations were substantially updated in 2024, including changes designed to expand treatment access and make certain treatment flexibilities permanent. States may impose additional requirements.
Practical issues for someone under supervision can include:
- location;
- dosing schedule;
- transportation;
- take-home medication policies;
- program hours;
- insurance and payment;
- reporting requirements; and
- compatibility with supervision schedules.
Buprenorphine and treatment through telehealth
Buprenorphine is another FDA-approved medication used to treat opioid use disorder. It can be provided through appropriately authorized clinicians and, in qualifying circumstances, through telemedicine.
Behavioral-health services more broadly may also be available through telehealth when clinically appropriate and legally permitted.
Remote services may be useful for people facing:
- rural provider shortages;
- transportation barriers;
- disability-related access issues;
- work schedules;
- caregiving responsibilities; or
- limited local treatment availability.
Separate three questions
Can the provider legally deliver this service remotely?
Is telehealth clinically appropriate for this service and patient?
Will the responsible court or supervision authority recognize that format?
Before relying on telehealth, confirm:
- provider licensure or authorization;
- clinical suitability;
- prescribing requirements where medication is involved;
- court or supervision acceptance;
- identity and attendance procedures;
- reporting capabilities; and
- any required in-person components.
Current federal prescribing context
As of August 17, 2026, federal telemedicine prescribing rules remain an evolving area. DEA and HHS have extended certain telemedicine prescribing flexibilities for controlled medications through December 31, 2026, subject to applicable federal requirements.
Because these rules can change, prescribing questions should be checked against current DEA, HHS, and provider guidance.
Treatment records, HIPAA and 42 CFR Part 2
Substance-use treatment information can receive heightened federal confidentiality protection.
42 CFR Part 2 protects qualifying substance-use disorder patient records maintained by Part 2 programs and certain lawful holders of those records.
Not every document containing information about substance use automatically becomes a Part 2 record.
HIPAA may also apply depending on the provider and circumstances.
The revised federal Part 2 rule became effective in 2024, and compliance with the updated requirements became mandatory on February 16, 2026.
Justice involvement does not automatically eliminate confidentiality protections.
Participation information and clinical information
| Participation information | More detailed clinical information |
|---|---|
| Enrolled | Diagnosis |
| Attended / did not attend | Counseling content |
| Currently participating | Treatment notes |
| Completed | Medication details |
| Discharged | Trauma history or clinical assessment findings |
This distinction is useful administratively, but it does not by itself determine what can legally be disclosed.
Providers should follow applicable Part 2, HIPAA, authorization, court-order, and other legal requirements rather than assuming that a supervision agency is automatically entitled to the complete clinical record.
Release-of-information forms
A valid authorization may permit treatment information to be disclosed to an identified recipient for an authorized purpose.
Before signing, understand:
- who will disclose the information;
- who will receive it;
- what information is covered;
- the purpose of disclosure;
- how long the authorization remains effective;
- applicable revocation rights; and
- whether Part 2 or another confidentiality rule applies.
The existence of probation, parole, or another supervision condition does not by itself make every release unlimited.
Insurance, Medicaid and treatment costs
Affordability can determine whether a person can begin or remain in care. Potential payment sources can include:
- Medicaid;
- Medicare when applicable;
- employer-sponsored health insurance;
- Marketplace coverage;
- private insurance;
- state or local behavioral-health funding;
- grant-funded treatment;
- sliding-fee programs; and
- self-pay arrangements.
Coverage varies by provider, plan, network status, level of care, medical-necessity criteria, and jurisdiction.
Questions to ask about payment
- Does the provider accept the person's insurance?
- Is the provider in network?
- Is prior authorization required?
- Is the recommended level of care covered?
- Are there deductibles or copayments?
- Are medication and laboratory services billed separately?
- What happens if coverage changes during treatment?
A court requirement does not necessarily make treatment free.
What if treatment cannot be afforded?
A financial barrier should be addressed before it becomes unexplained nonparticipation.
- Tell the provider about the cost barrier.
- Ask about Medicaid or other insurance options.
- Ask about sliding-fee or publicly funded services.
- Document reasonable attempts to locate affordable care.
- Determine whether another acceptable provider is available.
- Notify the responsible supervision authority as required.
- Seek legal assistance if inability to pay may affect compliance.
Inability to afford one provider does not necessarily eliminate the underlying legal requirement.
Transportation, geography and practical access
Clinically appropriate treatment can still become difficult to complete when a person cannot realistically reach or participate in the service.
Consider:
- distance;
- public transportation;
- treatment frequency;
- supervision reporting schedules;
- work hours;
- childcare;
- disability access;
- pharmacy access;
- medication pickup;
- testing requirements; and
- travel restrictions.
Telehealth can resolve some barriers, but not every service can be delivered remotely.
Changing treatment providers
A provider change may become necessary because of:
- relocation;
- insurance changes;
- provider closure;
- scheduling conflicts;
- accessibility problems;
- lack of availability;
- transfer to another level of care; or
- the provider no longer being able to meet treatment needs.
For someone under supervision, changing providers should be coordinated carefully.
Before leaving the original program, determine:
- whether notice or approval is required;
- whether the new provider will be accepted;
- whether records need to transfer;
- whether a gap in treatment will occur; and
- what updated documentation is required.
Co-occurring mental-health conditions
Mental-health conditions and substance-use disorders can occur together. Treatment planning may therefore involve integrated or coordinated services.
- psychiatric evaluation;
- medication management;
- individual psychotherapy;
- trauma treatment;
- substance-use counseling;
- crisis planning;
- peer recovery support; and
- case management.
A justice-system requirement is not a substitute for an individualized clinical assessment.
Disability access and treatment
People participating in treatment may also have disabilities affecting:
- mobility;
- hearing;
- vision;
- communication;
- cognition;
- learning;
- neurological functioning; or
- psychiatric functioning.
Public justice agencies and treatment providers may have obligations under federal or state disability law depending on their legal status and the circumstances.
Access issues may involve:
- accessible facilities;
- effective communication;
- accessible documents;
- reasonable modifications;
- assistive technology;
- scheduling; and
- remote access when appropriate.
For a broader discussion, see Disability-Aware Community Supervision .
Probation, parole, pretrial and supervised release are not the same
Probation
Probation is generally imposed by a court and can include treatment, testing, and other conditions. Governing authority and procedures vary by jurisdiction.
Parole or post-release supervision
Treatment requirements may arise through release conditions, parole authorities, correctional policy, or other governing mechanisms.
Pretrial supervision
Evaluation, treatment, or testing can sometimes be imposed while a criminal case remains pending.
Federal supervised release
Federal courts may impose substance-use treatment, testing, and related conditions as part of supervised release.
A rule applicable to one supervision system should not automatically be assumed to apply to another.
Treatment courts and specialty programs
Drug courts, DUI courts, veterans treatment courts, mental-health courts, and other specialty programs may have structured requirements beyond ordinary supervision.
Programs can differ in:
- eligibility;
- treatment frequency;
- provider requirements;
- drug and alcohol testing;
- judicial review;
- phase progression;
- incentives and sanctions;
- reporting; and
- graduation requirements.
Participants should rely on the controlling court order and current program requirements.
Before choosing a treatment provider
Provider qualifications
- Is the provider properly licensed or otherwise authorized?
- Does it provide the needed service?
- Does it offer the recommended level of care?
Court or supervision acceptance
- Will the responsible authority recognize the provider?
- Are particular credentials required?
- What documentation must be produced?
Availability
- Is the provider accepting new patients?
- How soon can evaluation or treatment begin?
Format
- In person?
- Telehealth?
- Hybrid?
- Residential?
Cost
- Insurance accepted?
- Medicaid accepted?
- Self-pay cost?
- Sliding-fee options?
- Financial assistance?
Documentation
Can the provider supply required enrollment, attendance, progress, discharge, or completion information consistent with applicable confidentiality rules?
Accessibility
- Physical access?
- Effective communication?
- Language access?
- Disability accommodations?
- Transportation?
Medication
If medication is clinically indicated, can the provider offer it or coordinate appropriate medical treatment?
15 questions to ask a treatment provider
- Do you provide substance-use evaluations?
- What levels or types of treatment do you provide?
- Do you serve people under probation, parole, pretrial supervision, or court orders?
- Can you provide required participation or completion documentation?
- Do you accept my insurance or Medicaid?
- What are the likely out-of-pocket costs?
- Is telehealth available?
- Do you provide or coordinate drug and alcohol testing?
- Do you treat co-occurring mental-health conditions?
- Do you provide or coordinate medication for opioid use disorder?
- What happens when an appointment is missed?
- How are transfers and discharges handled?
- What information can be provided to supervision agencies?
- What authorization forms may be required?
- What disability, communication, or language-access services are available?
A practical treatment-compliance workflow
-
Read the condition.
Identify exactly what the court order or supervision instructions require. -
Determine whether an evaluation is required.
Do not assume the appropriate treatment service before the required assessment is completed. -
Confirm provider acceptance.
Verify whether the provider and service satisfy the applicable requirement. -
Check access and affordability.
Address insurance, cost, transportation, scheduling, telehealth, language access, and disability needs. -
Begin the required services.
Follow applicable supervision instructions and the clinically appropriate treatment plan. -
Keep administrative records.
Maintain relevant enrollment, appointment, payment, attendance, and completion documentation. -
Address problems early.
Report provider closure, hospitalization, inability to pay, transportation problems, scheduling conflicts, or other significant barriers through the appropriate process. -
Confirm completion.
Determine what documentation must be obtained and where it must be submitted.
For treatment providers serving justice-involved patients
Treatment providers can reduce administrative confusion by publishing accurate information about:
- services offered;
- levels and settings of care;
- licensing or authorization;
- populations served;
- locations;
- telehealth availability;
- insurance participation;
- Medicaid participation;
- self-pay options;
- intake procedures;
- accessibility;
- medication services;
- documentation capabilities; and
- experience serving justice-involved patients.
Providers should avoid describing themselves as “court approved,” “probation approved,” or similarly endorsed unless that representation can be substantiated for the relevant jurisdiction and service.
A more accurate description may be that the organization serves justice-involved clients, with individuals advised to confirm whether its services satisfy their particular court or supervision requirements.
For courts, supervision agencies and service coordinators
Clear referral instructions can reduce participant confusion and provider workload.
Useful information can include:
- the exact service required;
- whether evaluation alone satisfies the requirement;
- required provider credentials;
- whether clinical recommendations must be followed;
- acceptable service formats;
- deadlines;
- reporting expectations;
- geographic requirements;
- where documentation must be submitted; and
- procedures when treatment is unavailable, inaccessible, or unaffordable.
Clear instructions help distinguish legal and administrative requirements from clinical treatment decisions.
Find treatment and behavioral-health resources
OACRA's service directories can be used to locate treatment and behavioral-health resources by jurisdiction.
Directory information is a starting point for direct verification. Before beginning services, confirm:
- current availability;
- qualifications or licensure;
- treatment type and level of care;
- eligibility;
- insurance and cost;
- service area;
- telehealth availability;
- medication services when relevant;
- accessibility;
- documentation capabilities; and
- court or supervision acceptance.
Individuals contact providers directly. OACRA does not select treatment providers, make clinical referrals, determine treatment eligibility, prescribe treatment, or guarantee that a particular provider or service will satisfy a court or supervision requirement.
The central distinction
Supervision-related treatment operates at the intersection of legal requirements, supervision administration, and clinical care.
Those roles can overlap, but they are not identical.
Effective navigation requires understanding:
- what the written condition requires;
- what authority the supervising agency has;
- what the clinical assessment recommends;
- which providers will be accepted;
- whether treatment is accessible and affordable;
- what information can lawfully be disclosed;
- what documentation is required; and
- what happens when treatment changes or is interrupted.
The objective is not simply to find a treatment program. It is to identify appropriate services that can actually be accessed, funded, completed, documented, and recognized under the applicable supervision requirements.
Frequently asked questions
Does everyone ordered to obtain a substance-use evaluation have to enter treatment?
Not necessarily. An evaluation and treatment are different. What happens after the evaluation depends on the controlling legal requirement, assessment results, program rules, and subsequent authorized instructions.
Can probation choose the treatment provider?
Sometimes probation or another supervising authority may have a role in selecting, approving, or coordinating providers. The scope of that authority varies by jurisdiction, condition, and supervision system.
Does a licensed treatment provider automatically count for court?
No. Professional licensure or facility authorization and court or supervision acceptance are different concepts.
Can court-related treatment be completed online?
Some treatment services may be provided through telehealth. Provider authority, clinical appropriateness, prescribing requirements, program rules, and court or supervision acceptance still need to be considered.
Can someone use methadone or buprenorphine while on probation?
Prescribed medication for opioid use disorder is recognized evidence-based treatment. Federal ADA protections can apply to people in recovery from OUD who are not currently engaging in illegal drug use, including people taking legally prescribed OUD medication. Individual legal and clinical circumstances still matter.
Does probation automatically get the entire treatment record?
No. Qualifying substance-use disorder records may be subject to 42 CFR Part 2, and HIPAA or other laws may also apply. What may be disclosed depends on the provider, record, consent, court authority, and applicable law.
What if treatment is unaffordable?
Raise the barrier promptly. Ask about Medicaid, insurance, sliding-fee arrangements, publicly funded programs, alternative acceptable providers, and the applicable process for notifying supervision.
What if the treatment provider closes?
Preserve available documentation, follow applicable supervision reporting requirements, and determine whether another acceptable provider is required.
Is a positive drug test automatically a probation violation?
Not necessarily. Treatment response and legal consequences depend on the actual conditions, jurisdiction, testing circumstances, and case. A positive result can have both clinical and supervision implications.
Is treatment completion the same as attending a set number of sessions?
Not always. Treatment programs and supervision authorities may have different completion and documentation standards.
Official sources and further reading
- SAMHSA — Treatment Types for Mental Health, Drugs and Alcohol
- SAMHSA — Substance Use Disorder Treatment Options
- SAMHSA — Opioid Treatment Program regulations under 42 CFR Part 8
- U.S. Department of Health and Human Services — HIPAA and 42 CFR Part 2
- U.S. Department of Justice / ADA.gov — The ADA and Opioid Use Disorder
- U.S. Courts — Substance Abuse Treatment, Testing, and Abstinence
- U.S. Drug Enforcement Administration — Telemedicine prescribing flexibilities through 2026
- FindTreatment.gov — Federal behavioral-health treatment locator
Last reviewed August 17, 2026. Treatment, confidentiality, medication, supervision, licensing, insurance, telemedicine, and court requirements vary by jurisdiction and individual circumstances. Verify current requirements with the responsible authority and qualified professionals.
